Sight Sciences [SGHT] vs Electromed [ELMD] Detailed Stock Comparison

Sight Sciences Inc.

NASDAQ
Loading...

Electromed Inc.

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Sight Sciences Inc. wins in 3 metrics, Electromed Inc. wins in 15 metrics, with 0 ties. Electromed Inc. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Sight Sciences Inc. Electromed Inc. Better
P/E Ratio (TTM) N/A 24.42 N/A
Price-to-Book Ratio 3.66 4.58 Sight Sciences Inc.
Debt-to-Equity Ratio 63.77 0.21 Electromed Inc.
PEG Ratio -7.85 0.56 Electromed Inc.
EV/EBITDA -5.39 15.10 Electromed Inc.
Profit Margin (TTM) -49.67% 13.06% Electromed Inc.
Operating Margin (TTM) -18.00% 19.16% Electromed Inc.
EBITDA Margin (TTM) N/A 19.16% N/A
Return on Equity -50.74% 20.20% Electromed Inc.
Return on Assets (TTM) -16.61% 13.62% Electromed Inc.
Free Cash Flow (TTM) $-29.92M $11.09M Electromed Inc.
1-Year Return 24.21% 85.05% Electromed Inc.
Price-to-Sales Ratio (TTM) 3.07 3.05 Electromed Inc.
Enterprise Value $182.12M $194.43M Electromed Inc.
EV/Revenue Ratio 2.35 2.82 Sight Sciences Inc.
Gross Profit Margin (TTM) 87.26% 78.42% Sight Sciences Inc.
Revenue per Share (TTM) $1 $8 Electromed Inc.
Earnings per Share (Diluted) $-0.74 $1.03 Electromed Inc.
Beta (Stock Volatility) 2.49 0.32 Electromed Inc.
Short % of Float 2.70% 2.47% Electromed Inc.

Sight Sciences Inc. vs Electromed Inc. Stock Performance Analysis

Loading Price Chart...

SGHT
ELMD

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Sight Sciences Inc.-2.14%8.42%0.80%34.22%-39.59%-32.89%
Electromed Inc.0.81%0.97%4.93%57.38%26.49%36.69%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Sight Sciences Inc.24.21%-39.50%-84.31%-84.31%-84.31%-84.31%
Electromed Inc.85.05%216.89%234.59%821.59%1,002.08%833.17%

Performance & Financial Health Analysis: Sight Sciences Inc. vs Electromed Inc.

MetricSGHTELMD
Market Information
Market Cap i$237.20M$212.52M
Market Cap CategoryMicro capMicro cap
10 Day Avg. Volume i460,06530,754
90 Day Avg. Volume i341,58543,435
Last Close$5.02$37.44
52 Week Range$3.11 - $9.24$17.73 - $40.00
% from 52W High-45.65%-6.40%
All-Time High$42.57 (Aug 02, 2021)$40.00 (May 29, 2026)
% from All-Time High-88.21%-6.40%
Growth Metrics
Quarterly Revenue Growth0.07%0.16%
Quarterly Earnings Growth0.07%0.40%
Financial Health
Profit Margin (TTM) i-0.50%0.13%
Operating Margin (TTM) i-0.18%0.19%
Return on Equity (TTM) i-0.51%0.20%
Debt to Equity (MRQ) i63.770.21
Cash & Liquidity
Book Value per Share (MRQ)$1.20$5.49
Cash per Share (MRQ)$1.70$1.67
Operating Cash Flow (TTM) i$-29,694,000$9.13M
Levered Free Cash Flow (TTM) i$-16,124,625$7.08M
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend iN/AN/A

Valuation & Enterprise Metrics Analysis: Sight Sciences Inc. vs Electromed Inc.

MetricSGHT (Apr 26, 2026)ELMD (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) iN/A24.42
Forward P/E i-7.8541.23
PEG Ratio i-7.850.56
Price to Sales (TTM) i3.073.05
Price to Book (MRQ) i3.664.58
Market Capitalization
Market Capitalization i$237.20M$212.52M
Enterprise Value i$182.12M$194.43M
Enterprise Value Metrics
Enterprise to Revenue i2.352.82
Enterprise to EBITDA i-5.3915.10
Risk & Other Metrics
Beta i2.490.32
Book Value per Share (MRQ) i$1.20$5.49

Financial Statements Comparison: Sight Sciences Inc. vs Electromed Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricSGHT (2025)ELMD (2025)
Revenue/Sales i77.36M64.00M
Cost of Goods Sold i10.70M14.03M
COGS % of Revenue i13.8%21.9%
Gross Profit i66.67M49.97M
Gross Margin i86.2%78.1%
Research & Development i14.61M996,000
Operating Income (EBIT) i-37.10M9.66M
Operating Margin i-48.0%15.1%
EBITDA i-36.76M10.83M
EBITDA Margin i-47.5%16.9%
Pre-Tax Income i-38.42M10.28M
Pre-Tax Income % of Revenue i-49.7%16.1%
Income Tax i10,0002.75M
Income Tax % of Revenue i0.0%4.3%
Net Income (Profit) i-38.43M7.54M
Profit Margin i-49.7%11.8%

Balance Sheet & Liquidity Metrics

MetricSGHT (2025)ELMD (2025)
Cash & Equivalents i91.97M15.29M
Total Current Assets i112.73M45.08M
Total Current Assets % of Revenue i145.7%70.4%
Total Current Liabilities i11.03M10.47M
Total Current Liabilities % of Revenue i14.3%16.4%
Long-Term Debt i40.30MN/A
Long-Term Debt % of Revenue i52.1%0.0%
Total Shareholders Equity i63.94M43.21M
Retained Earnings i-384.72M21.19M
Retained Earnings % of Revenue i-497.3%33.1%
Property, Plant & Equipment i2.65M4.63M

Cash Flow Statement Comparison

MetricSGHT (2025)ELMD (2025)
Operating Cash Flow i-24.47M11.64M
Operating Cash Flow % of Revenue i-31.6%18.2%
Capital Expenditures i-224,000N/A
Free Cash Flow i-29.92M11.09M
FCF Margin i-38.7%17.3%
Debt Repayment i0N/A
Common Stock Repurchase iN/A-10.00M

Short Interest & Institutional Ownership Analysis

MetricSGHTELMD
Shares Short i1.07M190,433
Short Ratio i2.423.79
Short % of Float i2.70%2.47%
Shares Outstanding i53.49M8.28M
Float Shares i35.29M6.49M
% Held by Insiders i20.96%21.45%
% Held by Institutions i48.49%59.90%
% Held by Public i30.55%18.65%

Dividend Analysis & Yield Comparison: Sight Sciences Inc. vs Electromed Inc.

MetricSGHTELMD
Last 12-Month Dividend iN/AN/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend iN/AN/A
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends iN/AN/A
Ex-Dividend DateN/AN/A